Exciting News! Lotus Clinical Research is now powered by ETQ Reliance Quality Management System!

Exciting News! Lotus Clinical Research is now powered by ETQ Reliance Quality Management System! We are thrilled to announce that Lotus Clinical Research has joined ETQ’s Reliance QMS. With ETQ Reliance, Lotus has digitized manual processes, centralized quality data, and automated core functions like document control and CAPA Plans. This partnership has greatly enhanced our … Read more

South Rampart Pharma Announces First Patient Enrolled in Multiple Ascending Dose Portion of Ongoing Phase 1 Clinical Trial

South Rampart Pharma Announces First Patient Enrolled in Multiple Ascending Dose Portion of Ongoing Phase 1 Clinical Trial  – SRP-001, a novel, non-opioid investigational drug that avoids the liver toxicity associated with acetaminophen, positioned to address the unmet medical need for non-toxic and non-addictive acute and chronic pain therapeutics –  – Data expected in 3Q 2023 – NEW … Read more

Erin Berg Introduced as Director of Project Management at Lotus Clinical Research

We are very excited to introduce Erin Berg as our Director of Project Management at Lotus Clinical Research. In her role, Erin will be leveraging her extensive experience to oversee and deliver Early Development Service (EDS) trials. With a wealth of experience and a proven track record of success in global project management and clinical study … Read more